- Home
- FDMT vs MG Comparison
FDMT vs MG Comparison
Compare FDMT & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | MG |
|---|---|---|
| Founded | 2013 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 481.7M |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FDMT | MG |
|---|---|---|
| Price | $9.49 | $17.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $31.71 | N/A |
| AVG Volume (30 Days) | ★ 783.4K | 117.1K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | $85,209,000.00 | ★ $700,970,000.00 |
| Revenue This Year | N/A | $5.47 |
| Revenue Next Year | $70.28 | $3.59 |
| P/E Ratio | ★ N/A | $32.28 |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $2.89 | $7.06 |
| 52 Week High | $12.34 | $17.35 |
Technical Indicators
Market Signals| Indicator | FDMT | MG |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 74.21 |
| Support Level | $8.41 | $13.75 |
| Resistance Level | $9.78 | N/A |
| Average True Range (ATR) | 0.64 | 0.51 |
| MACD | -0.01 | 0.23 |
| Stochastic Oscillator | 41.98 | 93.15 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.